References
- Tytgat GNJ. Dilation therapy of benign esophageal stenosis. World J Surg 1989; 13: 142–8
- Penagini R, Al Dabbagh M, Misiewicz JJ, Evans PF, Trotman IF. Effect of dilatation of peptic esophageal strictures on gastroesophageal reflux, dysphagia, and stricture diameter. Dig Dts Sci 1988; 33: 389–92
- Patterson DJ, Graham DY, Smith JL, et al. Natural history of benign esophageal stricture treated by dilatation. Gastroenterology 1983; 85: 346–50
- Ogilvie AL, Ferguson R, Atkinson M. Outlook with conservative treatment of peptic oesophageal stricture. Gut 1980; 21: 23–5
- Hands LJ, Papavramidis S, Bishop H, Dennison AR, McLntyre RL, Kettlewell MGW. The natural history of peptic oesophageal strictures treated by dilatation and antireflux therapy alone. Ann R Coll Surg Engl 1989; 71: 306–9
- Orr WC, Robinson MG, Humphries TJ, Antonello J, Cagliola A. Dose-response effect of famotidine on patterns of gastro-oesophageal reflux. Aliment Pharmacol Ther 1988; 2: 229–35
- Tytgat GNJ, Nio CY, Schotborgh RH. Reflux esophagitis. Scand J Gastroenterol 1990; 25: 1–12, Suppl 175
- Pace F, Sangaletti O, Bianchi Porro G. Daytime reduction of gastrooesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment. Gut 1990; 31: 1025–9
- Boyd EJS, Wood JR. H2-receptor antagonists in the treatment of reflux oesophagitis. Scand J Gastroenterol 1989; 24: 136–43, Suppl 171
- Ferguson R, Dronfield MW, Atkinson M. Cirnetidine in the treatment of reflux oesophagitis with peptic strictures. Br Med J 1979; 2: 472–4
- Starlingcr M, Appel WH, Schemper M, Schiessel R. Long-term treatment of peptic esophageal stenosis with dilatation and cirnetidine: factors influencing the clinical result. Eur Surg Res 1985; 17: 207–14
- Tytgat GNJ, Nicolai JJ, Reman FC. Efficacy of different doses of cirnetidine in the treatment of reflux esophagitis. A review of three large, double-blind, controlled trials. Gastroenterology 1990; 99: 629–34
- Stalnikowicz-Darvasi R. H2 antagonists in the treatment of reflux esophagitis: a critical analysis. Am J Gastroenterol 1989; 84: 245–8
- McCallum RW, Sontag SJ, Vlahcevic ZR, et al. Ranitidine versus placebo in long-term treatment of gastroesophageal reflux (GERD). Gastroenterology 1985; 80: 864
- Armstrong D, Blum AL. Rezitic study group. Full dose H2 receptor antagonist prophylaxis does not prevent relapse of reflux oesophagitis. Gut 1989; 30: A1494
- Watson A. Reflux stricture of the oesophagus. Br J Surg 1987; 74: 443–8
- Lundell L, Backman L, Ekström P, et al. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses' of H2-receptor antagonists. Aliment Pharmacol Ther 1990; 4: 145–55
- Dakkak M, Bennett JR. Balloon technology and its applications in gastrointestinal endoscopy. Bailliere's Clin Gastroenterol 1991; 5: 195–208